These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20015152)

  • 21. Interferon for hepatitis C patients with psychiatric disorders.
    Wilson MS
    Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569921
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
    Tsang OT; Zee JS; Chan JM; Li RS; Kan YM; Li FT; Lo FH; Chow DA; Cheung KW; Chan KH; Yeung YW; Ng FH; Li MK; Kwan WK; Lai TS
    J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).
    Fabrizi F; Aghemo A; Moroni G; Passerini P; D'Ambrosio R; Martin P; Messa P
    Dig Dis Sci; 2014 Mar; 59(3):691-5. PubMed ID: 24318802
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon-induced sarcoidosis.
    Cardoso C; Freire R; Alves A; Oliveira A
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
    Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.
    Cua IH; Kwan V; Henriquez M; Kench J; George J
    Gut; 2006 Oct; 55(10):1521-2. PubMed ID: 16966706
    [No Abstract]   [Full Text] [Related]  

  • 27. [Eliminating the gray zone. What can be done in normal ALT values?].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():75. PubMed ID: 15373059
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH
    Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases.
    Gitlin N
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):883-5. PubMed ID: 12172411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [APRICOT Study evaluated. Surprisingly high virologic response in HIV-HCV coinfection].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():74-5. PubMed ID: 15373058
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complete atrio-ventricular block: a rare complication of interferon alpha therapy].
    Roche NC; Paule P; Kerebel S; Gil JM; Heno P; Fourcade L
    Presse Med; 2011 Mar; 40(3):316-8. PubMed ID: 21242049
    [No Abstract]   [Full Text] [Related]  

  • 34. Recurrent myocardial ischaemia during combination antiviral therapy in a patient with chronic hepatitis C and normal aminotransferase levels.
    Lenci I; Piccolo P; Francioso S; Di Paolo D; Galante A; Angelico M
    Dig Liver Dis; 2008 Sep; 40(9):785-90. PubMed ID: 17913610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Side effects of the combined antiviral therapy in patients with chronic hepatitis C].
    Vashakidze ET; Gegeshidze TN; Zhamutashvili MT; Svanidze MB
    Georgian Med News; 2007; (148-149):26-8. PubMed ID: 17921538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C.
    Gheorghe L; Iacob S; Grigorescu M; Sporea I; Sirli R; Damian D; Gheorghe C; Iacob R
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):51-6. PubMed ID: 19337634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
    López V; Molina I; Monteagudo C; Jordá E
    Int J Dermatol; 2011 Mar; 50(3):287-91. PubMed ID: 21342161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial pneumonia recurrence during chronic hepatitis C treatment.
    Renou C; Germain S; Harafa A; Martin S; Larroque O; Muller P; Bertrand JJ; Halfon P
    Am J Gastroenterol; 2005 Jul; 100(7):1625-6. PubMed ID: 15984999
    [No Abstract]   [Full Text] [Related]  

  • 39. Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C.
    Monteagudo B; Grueiro MC; Vilas-Sueiro A; Campo-Cerecedo F
    Actas Dermosifiliogr (Engl Ed); 2019 Dec; 110(10):871-873. PubMed ID: 31387690
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection.
    Iacobellis A; Andriulli A
    Expert Opin Pharmacother; 2009 Aug; 10(12):1929-38. PubMed ID: 19563272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.